Resolute Science
resolutescience.com
Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$250k
5 rounds on record
Latest round
$250k
Venture round · May 2024 · 2 yr ago
Grants
$2.1M
2 grants · CORDIS
The money's age
Long since its last round
29 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 3, 2025
Took on debt financing $2.9M · SEC Form D
Feb 3, 2025
Took on debt financing $2.9M · SEC Form D
Aug 1, 2024
Won a grant $1.7M · CORDIS
Aug 1, 2023
Won a grant $399k · CORDIS
2020
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Debt Financing | Feb 2025 | $2.9M | — | SEC Form D |
| Debt Financing | Feb 2025 | $2.9M | — | SEC Form D |
| Grant | Aug 2024 | $1.7M | — | CORDIS |
| Venture round | May 2024 | $250k | — | SEC Form D |
| Grant | Aug 2023 | $399k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Resolute Science, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Andre BasbaumExecutive Officer, DirectorSEC Form D
Faith BarnettExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
TwoStep Therapeutics. Developing tumor-targeted therapies with broad applicability across solid tumors.
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
At Block Biosciences, we are developing first-in-class therapeutics designed to intercept the spread of cancer to the brain.
Precision Immunotherapies for Solid Tumors Built on Functional Biology at the Single-Cell Level.
Logic gated immunotherapies for cancer and autoimmune disease. Synolo Therapeutics is advancing a new class of therapeutics for cancer.
Surgery Reinvented - Current Surgical targets early-stage solid tumors in areas where traditional surgical techniques fail.
People
Andre Basbaum
Executive Officer, Director
Faith Barnett
Executive Officer, Director
James Mackay
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego
United States
HQ
Our Address
3210 Merryfield Row, San Diego, CA 92121